Company News
Wednesday preview: Fed rate decision, UK CPI in focus
All eyes in the middle of the week will be on the Federal Reserve, as rate-setters in Washington D. C. wrap up their two-day monetary policy meeting.
Ocado holds guidance as Q3 retail sales rise 7.2%
Online grocer and technology company Ocado maintained annual guidance after a 7. 2% rise in third-quarter retail revenues.
Director dealings: M&S non-exec invests, Brooks Macdonald CEO deals with options
Marks & Spencer was among those on the list of director buys on Tuesday after a non-executive director picked up more than 9,000 shares.
Accesso swings to statutory loss despite improved revenue
Leisure and entertainment sector technology provider Accesso reported a 3. 2% revenue increase in its interim results on Tuesday to $65. 78m.
Team17 maintains expectations as first-half earnings slip
Video games specialist Team17 reported a 31% increase in revenue in its half-year results on Tuesday, reaching £69. 7m, up from £53. 2m in the first half of 2022.
Fintel confident after robust first half of trading
Financial technology and support provider Fintel reported a 2% rise in core revenue in its half-year results on Tuesday, to £27. 6m.
Serica trims production guidance after completing Tailwind acquisition
Upstream oil and gas company Serica Energy noted the March acquisition of Tailwind Energy Investments in its interim results on Tuesday, which raised 2P reserves to 130 million barrels of oil equivalent as of 31 December.
Avacta upbeat on fresh data from chemotherapy trial
Life sciences company Avacta Group announced the successful completion of its sixth dose escalation cohort in the ALS-6000-101 phase one clinical trial on Tuesday, assessing the safety and tolerability of the drug, AVA6000.
Big Technologies revenue, earnings rise in first half
Monitoring technology specialist Big Technologies reported a 19% rise in first-half revenue on Tuesday, reaching £27. 3m, up from £22. 9m in the same period in 2022.
Renishaw revenue rises but full-year profit slips
Engineering company Renishaw said in its final results on Tuesday that despite facing challenging trading conditions, revenue rose to £688. 6m from £671. 1m year-on-year.
British Land upgrades guidance on retail park assets
British Land upgraded its guidance for its retail park assets on Tuesday, which it said had gained favour among a broad spectrum of customers, primarily for their affordability, convenience, and adaptability with omnichannel retailing.
C&C confident in recovering from ERP system difficulties
C&C Group said in a trading update on Tuesday that it expected its first-half operating profit to fall between €29m to €31m.
FirstGroup secures new West Coast Partnership rail contract
FirstGroup announced the attainment of a new National Rail contract (NRC) in collaboration with Trenitalia UK on Tuesday, with the Department for Transport (DfT) for the West Coast Partnership (WCP).
Moonpig holds guidance amid challenging conditions
Greeting card maker Moonpig on Tuesday reiterated half-year revenue guidance as trading remained in line with expectations.
SThree on track despite ongoing sales weakness
STEM-focused recruitment firm SThree said it remains on track for the full year but reported a continued decline in net fees in its third quarter as the placing of permanent jobs continued to decline.
Kingfisher lowers full-year expectations as Poland operations drag
Kingfisher lowered its profit expectations for the full year on Tuesday despite reporting a slight increase in first-half sales of 1. 1% to £6. 88bn, with like-for-like sales slightly ahead of expectations.
Hargreaves Lansdown posts robust growth in clients, profit
Financial services provider Hargreaves Lansdown reported a robust set of full-year results on Tuesday.
Tui holds annual outlook on strong bookings, higher prices
Travel giant Tui on Tuesday held annual guidance on the back of a strong summer and solid bookings for this winter, underpinned by higher prices and despite extreme weather such as wildfires and floods in Europe.
GSK's HIV prevention drug gets the EU green light
Pharmaceutical giant GSK has announced that its Apretude drug for HIV prevention has received approval from the European Commission.